ArticleRSC advances2026
Comparative effects of tannic acid and ZnO nanoparticles on hydration, microstructure, and antimicrobial performance of Portland cement.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the well-documented antimicrobial performance of ZnO nanoparticles, their incorporation into Ordinary Portland cement (OPC) is often accompanied by unfavorable effects, including delayed setting and deterioration of early-age mechanical properties. This investigation evaluates tannic acid (TA), a bio-derived organic compound, as a sustainable alternative cement additive to nano-ZnO. OPC pastes were modified with varying dosages of TA or nano-ZnO, and their influence on setting characteristics, workability, hydration progress, chemically combined water, free lime content, compressive strength, pore structure, phase composition, and microstructural development was systematically investigated. The results show that TA accelerates hydration at low dosage (0.25%) but exhibits a retarding effect at higher content (1%), whereas nano-ZnO consistently retards hydration regardless of concentration. At 3 days of curing, OPC containing 0.25% nano-ZnO attained a compressive strength of 78.3 MPa, while a pronounced reduction to 7 MPa was observed at 1% addition. In contrast, TA-modified systems demonstrated more stable mechanical performance, achieving 68.3 MPa at 0.25% and maintaining approximately 50 MPa at 1%. BET/BJH pore structure analysis revealed that both additives at 0.25% induced significant pore refinement, reducing the mean pore diameter from 67.92 nm to 48.52 nm for TA and 45.57 nm for nano-ZnO. Mineralogical and microstructural analyses (XRD, FTIR, SEM/EDX) indicated that TA promotes silicate dissolution and enhances the formation of portlandite, stratlingite, and tobermorite-like CSH phases. Conversely, nano-ZnO was found to inhibit hydration through the formation of Zn(OH)
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.